148 related articles for article (PubMed ID: 14735165)
1. Negative regulation of ErbB family receptor tyrosine kinases.
Sweeney C; Carraway KL
Br J Cancer; 2004 Jan; 90(2):289-93. PubMed ID: 14735165
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl.
Thien CB; Langdon WY
Oncogene; 1997 Dec; 15(24):2909-19. PubMed ID: 9416834
[TBL] [Abstract][Full Text] [Related]
3. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
Bowtell DD; Langdon WY
Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
[TBL] [Abstract][Full Text] [Related]
4. Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors.
Haglund K; Shimokawa N; Szymkiewicz I; Dikic I
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12191-6. PubMed ID: 12218189
[TBL] [Abstract][Full Text] [Related]
5. Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins.
Levkowitz G; Klapper LN; Tzahar E; Freywald A; Sela M; Yarden Y
Oncogene; 1996 Mar; 12(5):1117-25. PubMed ID: 8649804
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells.
Thomas CY; Chouinard M; Cox M; Parsons S; Stallings-Mann M; Garcia R; Jove R; Wharen R
Int J Cancer; 2003 Mar; 104(1):19-27. PubMed ID: 12532415
[TBL] [Abstract][Full Text] [Related]
7. ErbB receptor negative regulatory mechanisms: implications in cancer.
Sweeney C; Miller JK; Shattuck DL; Carraway KL
J Mammary Gland Biol Neoplasia; 2006 Jan; 11(1):89-99. PubMed ID: 16865534
[TBL] [Abstract][Full Text] [Related]
8. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
9. The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing.
Waterman H; Alroy I; Strano S; Seger R; Yarden Y
EMBO J; 1999 Jun; 18(12):3348-58. PubMed ID: 10369675
[TBL] [Abstract][Full Text] [Related]
10. Ligand-independent oncogenic transformation by the EGF receptor requires kinase domain catalytic activity.
Danielsen AJ; Maihle NJ
Exp Cell Res; 2002 Apr; 275(1):9-16. PubMed ID: 11925101
[TBL] [Abstract][Full Text] [Related]
11. EGF/ErbB receptor family in ovarian cancer.
Maihle NJ; Baron AT; Barrette BA; Boardman CH; Christensen TA; Cora EM; Faupel-Badger JM; Greenwood T; Juneja SC; Lafky JM; Lee H; Reiter JL; Podratz KC
Cancer Treat Res; 2002; 107():247-58. PubMed ID: 11775453
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of EphA2 receptor by Cbl.
Wang Yj; Ota S; Kataoka H; Kanamori M; Li Zy; Band H; Tanaka M; Sugimura H
Biochem Biophys Res Commun; 2002 Aug; 296(1):214-20. PubMed ID: 12147253
[TBL] [Abstract][Full Text] [Related]
13. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene.
Thien CB; Langdon WY
Oncogene; 1997 May; 14(18):2239-49. PubMed ID: 9174060
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor (EGFR) signaling in cancer.
Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
[TBL] [Abstract][Full Text] [Related]
15. Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1.
Cao Z; Wu X; Yen L; Sweeney C; Carraway KL
Mol Cell Biol; 2007 Mar; 27(6):2180-8. PubMed ID: 17210635
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
17. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes.
Wu CJ; Qian X; O'Rourke DM
DNA Cell Biol; 1999 Oct; 18(10):731-41. PubMed ID: 10541432
[TBL] [Abstract][Full Text] [Related]
18. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL
Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873
[TBL] [Abstract][Full Text] [Related]
19. Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases.
Peschard P; Park M
Cancer Cell; 2003 Jun; 3(6):519-23. PubMed ID: 12842080
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic M3 and epidermal growth factor receptors activate mutually inhibitory signaling cascades in human neuroblastoma SH-SY5Y cells.
Zhang L; Jope RS
Biochem Biophys Res Commun; 1999 Feb; 255(3):774-7. PubMed ID: 10049786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
